Vollum Institute, Oregon Health & Science University, Portland, Oregon 97239, USA.
Mol Pharmacol. 2012 Nov;82(5):983-92. doi: 10.1124/mol.112.081547. Epub 2012 Aug 22.
μ-Opioid receptor desensitization is considered an initial step in the development of tolerance. Curiously, the commonly used opioid morphine produces robust tolerance but minimal acute desensitization. This study was designed to test the hypothesis that desensitization is indeed present in morphine-treated animals and is distinguished from cellular tolerance by time course of recovery and mechanism. To induce tolerance, rats were treated with continuously released morphine for 1 week. Morphine-mediated activation of G protein-coupled inwardly rectifying potassium conductance was measured using voltage-clamp recordings from locus ceruleus neurons in brain slices from naive or morphine-treated rats. Cellular tolerance was observed as a decrease in morphine efficacy in slices from morphine-treated rats. This tolerance persisted for at least 6 h. An additional reduction in morphine-mediated current was observed when slices from morphine-treated rats were continuously maintained in morphine at approximately the circulating plasma concentration. This additional reduction recovered within 1 h after removal of morphine from the slice and represents desensitization that developed in the tolerant animal. Recovery from desensitization, but not long-lasting tolerance, was facilitated by protein phosphatase 1 (PP1) activity. Furthermore, desensitization, but not tolerance, was reversed by protein kinase C (PKC) inhibitor but not by an inhibitor of c-Jun N-terminal kinase. Therefore, morphine treatment leads to both long-lasting cellular tolerance and readily reversible desensitization, which are differentially dependent on PP1 and PKC activity and combine to result in a substantial decrease in morphine effectiveness. This PKC-mediated desensitization may contribute to the previously reported PKC-dependent reversal of behavioral tolerance.
μ-阿片受体脱敏被认为是耐受发展的初始步骤。奇怪的是,常用的阿片类药物吗啡产生了强大的耐受,但最小的急性脱敏。本研究旨在测试以下假设:脱敏确实存在于吗啡处理的动物中,并且通过恢复的时间过程和机制与细胞耐受区分开来。为了诱导耐受,用持续释放的吗啡处理大鼠 1 周。使用来自蓝斑神经元的脑片的电压钳记录来测量吗啡介导的 G 蛋白偶联内向整流钾电流的激活,来自未处理或吗啡处理的大鼠的脑片。观察到吗啡处理的大鼠脑片中吗啡效能下降,表明出现细胞耐受。这种耐受至少持续 6 小时。当来自吗啡处理的大鼠的脑片连续保持在约循环血浆浓度的吗啡中时,观察到吗啡介导的电流的进一步减少。这种额外的减少在从脑片中去除吗啡后 1 小时内恢复,代表在耐受动物中发展的脱敏。脱敏的恢复,但不是持久的耐受,由蛋白磷酸酶 1(PP1)活性促进。此外,脱敏,但不是耐受,由蛋白激酶 C(PKC)抑制剂而不是 c-Jun N 末端激酶抑制剂逆转。因此,吗啡处理导致持久的细胞耐受和容易逆转的脱敏,这两者都依赖于 PP1 和 PKC 活性的差异,并结合导致吗啡效力的显著降低。这种 PKC 介导的脱敏可能有助于先前报道的 PKC 依赖性行为耐受的逆转。